AMED: Amedisys, Inc. - Summary | Jitta

Amedisys, Inc.

NASDAQ:AMED

Notice
Stock data is unavailable or the company’s delisted.
Price
$100.99
Loss Chance
44.5%
6.12JITTA SCORE
151.27%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (57)
Recent Business Performance (79)
Financial Strength (88)
Return to Shareholders (41)
Competitive Advantage (72)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
CapExVery Low
Interest Coverage RatioVery Good
Cash Conversion CycleLess than 60 days
Revenue and EarningEarning decline from 2021-2024
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
6.12
151.27%
3.07
432.53%
Health Care Services
6.04
5.69%
7.88
34.33%
4.66
49.45%
COMPANY DESCRIPTION
Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer’s. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was formerly known as Analytical Nursing Management Corp. and changed its name to Amedisys, Inc. in August 1995. The company was founded in 1982 and is headquartered in Baton Rouge, Louisiana with an additional office in Nashville, Tennessee. As of August 14, 2025, Amedisys, Inc. operates as a subsidiary of Optum, Inc.